Results 221 to 230 of about 225,713 (333)
Microbiome modulation and behavioural improvements in children with fragile X syndrome following probiotic intake: A pilot study. [PDF]
Protic D +12 more
europepmc +1 more source
Mitochondrial DNA Depletion Syndrome 1 (MTDPS1)—A Novel Cause of Premature Ovarian Insufficiency
We describe a woman with MNGIE due to a novel homozygous TYMP nonsense variant and propose MNGIE as the cause of her premature ovarian insufficiency—a rarely reported association—highlighting the need to consider mitochondrial disease in unexplained POI, especially in atypical, consanguineous presentations. ABSTRACT Mitochondrial DNA depletion syndrome
Michael Matheou +3 more
wiley +1 more source
Dysfunctional neural dynamics associated with sensory phenotypes in Fragile X syndrome: insights from mouse models. [PDF]
Goel A +3 more
europepmc +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot +3 more
wiley +1 more source
Atypical Retinal Ganglion Cell Function in a Mouse Model of Fragile X Syndrome. [PDF]
Vlasits AL +5 more
europepmc +1 more source
ABSTRACT Introduction Despite the absence of official dietary guidelines for fibromyalgia, many patients adopt restrictive diets in an attempt to alleviate symptoms. Understanding their motivations and experiences is essential to inform patient‐centred care. Methods This qualitative study included 19 individuals with fibromyalgia who reported following
Laura Albaladejo +5 more
wiley +1 more source
FMRP restoration in parvalbumin interneurons: A circuit-specific improvement of visual learning in fragile X syndrome. [PDF]
Nareddula S +5 more
europepmc +1 more source
Rare FMR1 gene mutations causing fragile X syndrome: A review
Adam F Sitzmann +4 more
semanticscholar +1 more source
ABSTRACT Background Improving care and research for individuals with genetic intellectual disabilities (GID) requires the identification and measurement of relevant patient reported outcomes (PROs). PROs represent the patient perspective on their health status.
Nadia Y. van Silfhout +5 more
wiley +1 more source

